News

You are able to gift 5 more articles this month. Anyone can access the link you share with no account required. Learn more. It is very likely that most Mainers, even if they have never used a ...
The first in-house project to start clinical trials is ISM001-055, an anti-fibrotic compound intended as a treatment for idiopathic pulmonary fibrosis (IPF), which is currently being tested in a ...